Ignite Creation Date:
2024-05-06 @ 2:56 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02163694
Status:
COMPLETED
Last Update Posted:
2024-02-23
First Post:
2014-05-19
Brief Title:
A Phase 3 Randomized Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib ABT-888 in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
Sponsor:
AbbVie
Organization:
AbbVie
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-19
First Submit QC Date:
June 12 2014
Study First Post Date:
2014-06-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-04-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-04-01
Disp First Submit QC Date:
April 1 2020
Disp First Post Date:
2020-04-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-02-19
Last Update Post Date:
2024-02-23
Last Update Post Date Type:
ACTUAL